Based on previous studies done in mice, researchers observed that GLP-1 agonists/DPP-4 inhibitors work to reduce inflammation in the gut, so they proposed that the same mechanism may occur in humans (5, 6)
It also plays a critical role in maintaining cellular health by directly neutralizing free radicals,
Mullen KD, Gacad R: Pathogenetic mechanisms of acute hepatic encephalopathy
In 2023, the FDA placed restrictions on peptides sold by compounding pharmacies, and Health Canada has issued warnings about unauthorized peptide use
And that one is considered a carrier vaccine
Nutritional Risks of Combining Fasting and GLP-1 Therapy The biggest risk when merging intermittent fasting with GLP-1 use is consuming too few calories during eating windows, leading to protein deficiency, micronutrient gaps, and loss of lean muscle mass